9-Didemethyl Minocycline (CAS 5874-95-3)

9-Didemethyl Minocycline, identified by the CAS number 5874-95-3, is a chemically modified derivative of minocycline, a member of the tetracycline antibiotics. This derivative is characterized by the removal of two methyl groups from the parent compound. The primary action of 9-Didemethyl Minocycline involves the inhibition of bacterial protein synthesis, a common mechanism among tetracyclines. It achieves this by binding to the 30S ribosomal subunit in bacterial cells, blocking the attachment of aminoacyl-tRNA to the mRNA-ribosome complex at the ribosomal acceptor (A) site. This interruption prevents the incorporation of amino acids into peptide chains, thereby inhibiting the elongation of proteins essential for bacterial growth and viability. In research contexts, 9-Didemethyl Minocycline has been utilized to study the structural and functional impacts of demethylation on the pharmacodynamic properties of tetracyclines. Investigations involving this compound have contributed to a deeper understanding of how structural changes affect the binding efficiency and specificity to bacterial ribosomes, potentially leading to a reduced propensity for resistance development. Additionally, this compound has been instrumental in probing the molecular basis of tetracycline interaction with ribosomal RNA, which is crucial for designing novel inhibitors that can target resistant bacterial strains effectively.